心脏骤停后脑损伤的神经保护方法:当前趋势和潜在途径
相关实验视频
Updated: Jul 21, 2026
09:29
2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
Published on: June 22, 2013
20.0K
Subash Marasini1, Xiaofeng Jia1,2,3,4
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Journal of stroke
|June 5, 2024
概括
医院外心脏骤停 (OHCA) 后生存率的提高需要更好的脑损伤治疗方法. 本综述探讨了用于心脏骤停 (CA) 后神经保护的气体,药物和干细胞疗法.
科学领域:
- 神经科学是一个神经科学.
- 紧急医疗 紧急医疗
- 再生医学是一种再生医学.
背景情况:
- 由于旁观者心肺复苏和公共通道除,医院外心脏骤停 (OHCA) 的生存率有所改善.
- OHCA幸存者经常经历无氧/再输血脑损伤的神经损伤,影响生活质量.
- 目前的治疗方法,如体外膜氧化和有针对性的温度管理是有效的,但成本高昂.
研究的目的:
- 审查最近的临床前和临床研究 (2016-2023) 关于心脏骤停 (CA) 的神经保护策略.
- 评估基于气体介导,药理学和干细胞的方法,以缓解CA后的脑损伤.
- 突出新疗法的潜力,以改善CA后的神经结果.
主要方法:
- 在PubMed数据库中搜索有关心脏骤停后神经保护的研究.
- 包括临床前 (动物,猪模型) 和临床研究.
- 专注于气体介导,药理学和基于干细胞的干预措施.
主要成果:
- 使用气体 (NO,H2,H2S,CO,Ar,Xe),药物和干细胞的临床前研究在CA的动物模型中显示出希望.
- 吸入气体和一些药理学剂在人体CA试验中未能显示治疗效果.
- 干细胞疗法尚未在CA的临床试验中进行测试,临床前数据有限.
结论:
- 虽然一些气体和药理疗法在临床试验中失败了,但对心脏骤停后神经保护的研究仍在继续.
- 干细胞治疗显示了CA后神经恢复的潜力,但需要进一步的临床前研究来阐明机制并提高疗效.
- 开发具有成本效益的神经保护策略对于改善OHCA幸存者的生活质量至关重要.
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...